Skip to main content
Previous Poster Home Next

Treatment Patterns in Surgically Resected NSCLC Since the Introduction of ImmunoOncology Agents
07:30am - 03:35pm EST - April 5, 2024

  • Information
  • Resources
  • Play Recording

Treatment Patterns in Surgically Resected NSCLC Since the Introduction of ImmunoOncology Agents icon

Abstract: JNCCN23-0677 https://jnccn.org/view/journal...


Author(s):
  • Dr. Daniel Simmons, PharmD, MS, Director of Oncology Outcomes Research, AstraZeneca

Tags: Member Institution Outcomes and Health Services Research

Display Label Action
Treatment Patterns in Surgically Resected NSCLC Since the Introduction of Immuno-Oncology Agents Final Poster 2.pdf Download Handout
AC24P45 - Treatment Patterns in Surgically Resected NSCLC Since the Introduction of ImmunoOncology Agents Download MP3